Fluindapyr; Pesticide Tolerances, 13459-13465 [2021-04786]
Download as PDF
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Rules and Regulations
(3) Employees and officers may ask
questions, raise concerns, or report instances
of non-compliance with this policy and/or
any of the existing underlying relevant
policies by contacting the following:
[COMPLIANCE HELP LINE OR E–MAIL].
G. Certification
On an annual basis, the ECIP recipient will
deliver to the Department of the Treasury a
certification, executed by two senior
executive officers (one of which must be
either the ECIP recipient’s principal
executive officer or principal financial
officer) certifying that (i) the Organization is
in compliance with this policy and (ii) the
approval of any expenditure requiring the
prior approval of any senior executive officer,
any executive officer of a substantially
similar level of responsibility, or the board of
directors (or a committee of such board), was
properly obtained with respect to each such
expenditure.
David Lebryk,
Fiscal Assistant Secretary.
[FR Doc. 2021–04900 Filed 3–5–21; 11:15 am]
BILLING CODE 4810–AK–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 62
[EPA–R03–OAR–2019–0527.; FRL–10020–
90–Region 3]
Approval and Promulgation of State
Air Quality Plans for Designated
Facilities and Pollutants; State of
Maryland; Control of Emissions From
Existing Sewage Sludge Incineration
Units; Correction
Environmental Protection
Agency (EPA).
ACTION: Final rule; correction.
AGENCY:
The Environmental Protection
Agency (EPA) issued a final rule on
February 9, 2021 entitled ‘‘Approval
and Promulgation of State Air Quality
Plans for Designated Facilities and
Pollutants; State of Maryland; Control of
Emissions from Existing Sewage Sludge
Incineration Units.’’ This document
corrects an error in the rule language of
the final rule pertaining to EPA’s
approval of Maryland’s negative
declaration regarding the existence of
Sewage Sludge Incineration (SSI) units
in the state submitted by the State of
Maryland.
DATES: Effective on March 11, 2021.
FOR FURTHER INFORMATION CONTACT:
Matthew Willson, Permits Branch
(3AD10), Air & Radiation Division, U.S.
Environmental Protection Agency,
Region III, 1650 Arch Street,
Philadelphia, Pennsylvania 19103. The
telephone number is (215) 814–5795.
khammond on DSKJM1Z7X2PROD with RULES
SUMMARY:
VerDate Sep<11>2014
16:19 Mar 08, 2021
Jkt 253001
Mr. Willson can also be reached via
electronic mail at Willson.Matthew@
epa.gov.
SUPPLEMENTARY INFORMATION: On
February 9, 2021, (86 FR 8699), EPA
published a final rule action
announcing our approval of Maryland’s
negative declaration regarding the
existence of SSI units in the state. In the
document, we inadvertently indicated
that a section should be added to the
Code of Federal Regulations (CFR) at 40
CFR 62.4690 for air emissions from
existing SSI units. The intent of the rule
was to add a section for air emissions
from existing SSI units at 40 CFR
62.5170. This document corrects the
erroneous language.
Need for Correction
As published, the final rule would
amend subpart T, which is for the
approval of state plans for designated
facilities and pollutants for the state of
Louisiana. The intent of the final rule
was to change the approval of state
plans for designated facilities and
pollutants for the State of Maryland.
This correction will ensure that the
correct section of the CFR, which for
Maryland is subpart V, is amended.
Section 553 of the Administrative
Procedure Act, 5 U.S.C. 553(b)(3)(B),
provides that, when an agency for good
cause finds that notice and public
procedure are impracticable,
unnecessary or contrary to the public
interest, the agency may issue a rule
without providing notice and an
opportunity for public comment. We
have determined that there is good
cause for making this rule final without
prior proposal and opportunity for
comment because we are merely
correcting an incorrect citation in a
previous action. Thus, notice and public
procedure are unnecessary. We find that
this constitutes good cause under 5
U.S.C. 553(b)(3)(B).
In FR doc. 2021–02617 appearing on
page 8699 in the Federal Register of
Tuesday, February 9, 2021 the following
corrections are made:
Subpart V—[Corrected]
1. On page 8700, in the third column,
in part 62, in amendment 2, the
instruction ‘‘Add an undesignated
center heading and § 62.4690 to read as
follows:’’ is corrected to read ‘‘Add an
undesignated center heading and
§ 62.5170 to read as follows:’’
■ 2. On page 8700, in the third column,
the section heading ‘‘§ 62.4690
Identification of plan—negative
declaration.’’ is corrected to read
‘‘§ 62.5170 Identification of plan—
negative declaration.’’
■
PO 00000
Frm 00017
Fmt 4700
Sfmt 4700
13459
Dated: March 3, 2021.
Diana Esher,
Acting Regional Administrator EPA Region
III.
[FR Doc. 2021–04827 Filed 3–8–21; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2018–0551; FRL–10019–19]
Fluindapyr; Pesticide Tolerances
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes
tolerances for residues of fluindapyr in
or on multiple commodities which are
identified and discussed later in this
document. FMC Corporation requested
these tolerances under the Federal Food,
Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective
March 9, 2021. Objections and requests
for hearings must be received on or
before May 10, 2021, and must be filed
in accordance with the instructions
provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
INFORMATION).
SUMMARY:
The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2018–0551, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPP
Docket is (703) 305–5805.
Due to the public health concerns
related to COVID–19, the EPA Docket
Center (EPA/DC) and Reading Room is
closed to visitors with limited
exceptions. The staff continues to
provide remote customer service via
email, phone, and webform. For the
latest status information on EPA/DC
services and docket access, visit https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Marietta Echeverria, Registration
Division (7505P), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; main
ADDRESSES:
E:\FR\FM\09MRR1.SGM
09MRR1
13460
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Rules and Regulations
telephone number: (703) 305–7090;
email address: RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Publishing Office’s eCFR site at https://www.ecfr.gov/cgi-bin/
text-idx?&c=ecfr&tpl=/ecfrbrowse/
Title40/40tab_02.tpl.
khammond on DSKJM1Z7X2PROD with RULES
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2018–0551 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing and must be received
by the Hearing Clerk on or before May
10, 2021. Addresses for mail and hand
delivery of objections and hearing
requests are provided in 40 CFR
178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
VerDate Sep<11>2014
16:19 Mar 08, 2021
Jkt 253001
2018–0551, by one of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be CBI or
other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW, Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on
commenting or visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
II. Summary of Petitioned-For
Tolerance
In the Federal Register of May 9, 2019
(84 FR 20320) (FRL–9992–36), EPA
issued a document pursuant to FFDCA
section 408(d)(3), 21 U.S.C. 346a(d)(3),
announcing the filing of a pesticide
petition (PP 8F8685) by FMC
Corporation, 2929 Walnut Street,
Philadelphia, PA 19104. The petition
requested that 40 CFR part 180 be
amended by establishing tolerances for
residues of the fungicide, fluindapyr, 3(difluoromethyl)-N-(7-fluoro-2,3dihydro-1,1,3-trimethyl-1H-inden-4-yl)1-methyl-1H-pyrazole-4-carboxamide, in
or on almond, hulls at 15 parts per
million (ppm); aspirated grain fractions
at 60 ppm; cattle, fat at 0.15 ppm; cattle,
meat byproducts at 0.6 ppm; field corn,
grain at 0.01 ppm; field corn, oil at 0.03
ppm; fruit, small vine-climbing except
fuzzy kiwifruit, crop subgroup 13–07F
at 3 ppm; grain, cereal, crop group 15,
except rice and corn at 0.9 ppm; grain,
cereal, forage, crop group 16, except
rice, forage at 15 ppm; grain, cereal, hay,
crop group 16 except rice, hay at 8 ppm;
grain, cereal, stover, crop group 16
except rice, stover, and sweet corn
stover at 4 ppm; grain, cereal, straw,
crop group 16, except rice, straw at 20
ppm; poultry, meat byproducts at 0.03
ppm; soybean, forage at 15 ppm;
soybean, hay at 30 ppm; soybean, hulls
at 0.6 ppm; soybean, seed at 0.2 ppm;
sweet corn, K+CWHR at 0.01 ppm;
sweet corn, stover at 20 ppm; swine,
meat byproducts at 0.02 ppm; and tree
nuts, crop group 14–12 at 0.04 ppm.
That document referenced a summary of
the petition prepared by FMC
Corporation, the registrant, which is
available in the docket, https://
www.regulations.gov. One comment was
PO 00000
Frm 00018
Fmt 4700
Sfmt 4700
received on the notice of filing. EPA’s
response to this comment is discussed
in Unit IV.C.
Based upon review of the data
supporting the petition and in
accordance with its authority under
FFDCA section 408(d)(4)(A)(i) to
establish tolerances that vary from what
was requested, EPA is establishing
several tolerances at different levels
than were requested, including
additional livestock commodities as
necessary. In addition, tolerances for
fruit, small vine-climbing except fuzzy
kiwifruit crop group 13–07F and
soybeans were removed. The reasons for
these changes are explained in Unit
IV.D.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue. . . .’’
Consistent with FFDCA section
408(b)(2)(D), and the factors specified in
FFDCA section 408(b)(2)(D), EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for fluindapyr
including exposure resulting from the
tolerances established by this action.
EPA’s assessment of exposures and risks
associated with fluindapyr follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
E:\FR\FM\09MRR1.SGM
09MRR1
khammond on DSKJM1Z7X2PROD with RULES
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Rules and Regulations
subgroups of consumers, including
infants and children.
The target organs of fluindapyr are the
liver and thyroid. Liver effects include
hepatocellular hypertrophy, increased
liver weights, and bile duct hyperplasia
with correlated increases in alkaline
phosphatase (ALP), alanine
aminotransferase (ALT), and gamma
glutamyl transferase (GGT) at the
highest dose tested. Liver effects
progress with time in treated dogs,
while similar effects are not seen in rats
and mice at high dose levels. Liver
effects are seen in the mouse
carcinogenicity study at a higher dose
level than the liver effects observed in
dogs; the effects consisted of increased
incidence of hepatocellular alterations
(basophilic, eosinophilic, vacuolated),
necrosis, and pigmented macrophages.
Thyroid effects include increased
instances of follicular hypertrophy/
hyperplasia.
In the acute neurotoxicity study,
potential evidence of neurotoxicity in
the form of decreases in total and
ambulatory motor activities and in
rearing were seen in the rat. However,
no additional functional observation
(FOB) parameters were affected, and no
neuropathological findings of both
central and peripheral nerves were
observed.
There is no evidence of increased
quantitative or qualitative susceptibility
in the developmental toxicity studies in
rabbits or rats; or the reproductive
toxicity study in rats. With in-utero
exposure in the developmental toxicity
studies, fluindapyr did not produce any
adverse effects in either rat or rabbit
parental animals or fetuses at or
approaching the limit dose. In the
reproduction study, in parental animals
(P and F1 males and females),
fluindapyr induced an increase in
thyroid follicular hypertrophy/
hyperplasia. It also induced adverse
effects on a host of reproductive
parameters. It also produced adverse
offspring effects as indicated by
decreases in F1 and F2 pup body
weights in both sexes; thymus and
spleen weights were also decreased. The
parental, reproductive, and offspring
effects all occurred at the same dose
levels. The increased incidence of
thyroid follicular hypertrophy/
hyperplasia raised concerns for the
potential of thyroid effects on the
developing animals. EPA applied a 10X
safety factor to the appropriate exposure
scenarios to account for the
uncertainties associated with the life
stage susceptibility.
In the chronic toxicity/carcinogenicity
studies in rats and mice, there was no
evidence of carcinogenicity. The
VerDate Sep<11>2014
16:19 Mar 08, 2021
Jkt 253001
mutagenicity battery was negative.
Fluindapyr is classified as ‘‘Not Likely
to be Carcinogenic to Humans’’.
Specific information on the studies
received and the nature of the adverse
effects caused by fluindapyr as well as
the no-observed-adverse-effect-level
(NOAEL) and the lowest-observedadverse-effect-level (LOAEL) from the
toxicity studies can be found at https://
www.regulations.gov in document
‘‘Fluindapyr: Human Health Risk
Assessment for Section 3 Registration
and Tolerance Requests for a New
Active Ingredient Proposed for Use on
Cereal Grains Crop Group 15 except
Rice; Forage, Fodder and Straw of
Cereal Grains Crop Group 16; and
Soybean’’ (hereinafter ‘‘Fluindapyr
Human Health Risk Assessment’’) on
pages 14–20 in docket ID number EPA–
HQ–OPP–2018–0551.
B. Toxicological Points of Departure/
Levels of Concern
Once a pesticide’s toxicological
profile is determined, EPA identifies
toxicological points of departure (POD)
and levels of concern to use in
evaluating the risk posed by human
exposure to the pesticide. For hazards
that have a threshold below which there
is no appreciable risk, the toxicological
POD is used as the basis for derivation
of reference values for risk assessment.
PODs are developed based on a careful
analysis of the doses in each
toxicological study to determine the
dose at which no adverse effects are
observed (the NOAEL) and the lowest
dose at which adverse effects of concern
are identified (the LOAEL). Uncertainty/
safety factors are used in conjunction
with the POD to calculate a safe
exposure level—generally referred to as
a population-adjusted dose (PAD) or a
reference dose (RfD)—and a safe margin
of exposure (MOE). For non-threshold
risks, the Agency assumes that any
amount of exposure will lead to some
degree of risk. Thus, the Agency
estimates risk in terms of the probability
of an occurrence of the adverse effect
expected in a lifetime. For more
information on the general principles
EPA uses in risk characterization and a
complete description of the risk
assessment process, see https://
www2.epa.gov/pesticide-science-andassessing-pesticide-risks/assessinghuman-health-risk-pesticide.
A summary of the toxicological
endpoints for fluindapyr used for
human risk assessment can be found in
the Fluindapyr Human Health Risk
Assessment.
PO 00000
Frm 00019
Fmt 4700
Sfmt 4700
13461
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to fluindapyr, EPA considered
exposure under the petitioned-for
tolerances. EPA assessed dietary
exposures from fluindapyr in food as
follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1-day or single
exposure. Such effects were identified
for fluindapyr. In estimating acute
dietary exposure, EPA used 2003–2008
food consumption information from the
United States Department of Agriculture
(USDA) Nationwide Health and
Nutrition Examination Survey, What We
Eat in America (NHANES/WWEIA). As
to residue levels in food, the acute
analysis assumed 100% crop treated
(PCT) for all commodities, highest
average field trial (HAFT) residue
values, empirical and default processing
factors, and anticipated livestock
residues based on calculated livestock
dietary burden and tissue transfer rates
from the livestock feeding studies.
ii. Chronic exposure. In conducting
the chronic dietary exposure assessment
EPA used 2003–2008 food consumption
data from the USDA’s NHANES/
WWEIA. As to residue levels in food,
chronic analysis assumed 100 PCT for
all commodities, field trial mean residue
values, empirical and default processing
factors, and anticipated livestock
residues based on calculated livestock
dietary burden and tissue transfer rates
from the livestock feeding studies and
metabolite ratios from the metabolism
studies.
iii. Cancer. Based on the data
summarized in Unit III.A., EPA has
concluded that fluindapyr does not pose
a cancer risk to humans. Therefore, a
dietary exposure assessment for the
purpose of assessing cancer risk is
unnecessary.
iv. Anticipated residue. Section
408(b)(2)(E) of FFDCA authorizes EPA
to use available data and information on
the anticipated residue levels of
pesticide residues in food and the actual
levels of pesticide residues that have
been measured in food. If EPA relies on
such information, EPA must require
pursuant to FFDCA section 408(f)(1)
that data be provided 5 years after the
tolerance is established, modified, or
left in effect, demonstrating that the
levels in food are not above the levels
anticipated. For the present action, EPA
will issue such data call-ins as are
required by FFDCA section 408(b)(2)(E)
E:\FR\FM\09MRR1.SGM
09MRR1
khammond on DSKJM1Z7X2PROD with RULES
13462
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Rules and Regulations
and authorized under FFDCA section
408(f)(1). Data will be required to be
submitted no later than 5 years from the
date of issuance of these tolerances.
EPA did not use information on the
percent of food actually treated in the
dietary assessment for fluindapyr; 100
PCT was assumed for all food
commodities.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
for fluindapyr in drinking water. These
simulation models take into account
data on the physical, chemical, and fate/
transport characteristics of fluindapyr.
Further information regarding EPA
drinking water models used in pesticide
exposure assessment can be found at
https://www2.epa.gov/pesticide-scienceand-assessing-pesticide-risks/aboutwater-exposure-models-used-pesticide.
Using the Pesticide Water Calculator
(PWC, version 1.52), the estimated
drinking water concentrations (EDWCs)
of fluindapyr were determined to be
higher in groundwater than in surface
water for both acute and chronic
exposure durations. The following
groundwater EDWCs were used directly
in the dietary exposure model to
account for the contribution of
fluindapyr and relevant transformation
products (3–OH–F9990 and 1–COOH–
F9990) residues in drinking water as
follows: 254.1 ppb was used in the acute
assessment and 217.8 ppb was used in
the chronic assessment.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets).
Fluindapyr is currently registered for
the following use that could result in
residential exposures: Golf course turf.
The currently registered use on golf
courses will result in short-term (1 to 30
days) residential post-application
dermal exposures to adult, youth 11 to
less than 16 years old, and children 6
to less than 11 years old. Further
information regarding EPA standard
assumptions and generic inputs for
residential exposures may be found at
https://www.epa.gov/pesticides/trac/
science/trac6a05.pdf.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
VerDate Sep<11>2014
16:19 Mar 08, 2021
Jkt 253001
substances that have a common
mechanism of toxicity.’’
Unlike other pesticides for which EPA
has followed a cumulative risk approach
based on a common mechanism of
toxicity, EPA has not made a common
mechanism of toxicity finding as to
fluindapyr and any other substances
and fluindapyr does not appear to
produce a toxic metabolite produced by
other substances. For the purposes of
this action, therefore, EPA has not
assumed that fluindapyr has a common
mechanism of toxicity with other
substances.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(C) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
FQPA Safety Factor (SF). In applying
this provision, EPA either retains the
default value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
2. Prenatal and postnatal sensitivity.
In the developmental toxicity studies
(rat and rabbit), fluindapyr did not
produce any adverse effects in parental
animals or fetuses at or approaching the
limit dose (1,000 mg/kg/day). In the
reproduction study, in parental animals
(P and F1 males and females),
fluindapyr induced an increase in
thyroid follicular hypertrophy/
hyperplasia. It also induced adverse
effects on a host of reproductive
parameters. There is no evidence of
increased quantitative or qualitative
susceptibility in the developmental
toxicity studies in rabbits or rats or the
reproductive toxicity study in rats. In
the 2-generation reproduction study in
rats, reproductive effects were observed,
and offspring toxicity (decreased pup
weights in F1 and F2 generation;
thymus and spleen weights were
decreased) was observed in the presence
(same dosage) of parental toxicity
(increase in thyroid follicular
hypertrophy/hyperplasia and
reproductive effects).
3. Conclusion. Due to the
uncertainties concerning the potential
life stage susceptibility related to
adverse thyroid effects seen in parental
animals of the reproductive study, EPA
is retaining the FQPA 10X SF for
PO 00000
Frm 00020
Fmt 4700
Sfmt 4700
exposure scenarios that rely on the
reproductive study in which such
effects were seen. For purposes of this
safety assessment, those scenarios are
the post-application short-term dermal
exposures and the short-term aggregate
risk assessment. For the acute and
chronic dietary assessments, EPA has
determined that reliable data show the
safety of infants and children would be
adequately protected if the FQPA SF
were reduced to 1X. That decision is
based on the following findings:
i. The toxicity database for fluindapyr
is complete. Fluindapyr caused an
increased in the thyroid follicular
hypertrophy/hyperplasia in the 2generation reproduction study. The
results of these findings raised concerns
about the potential impact to the
developing brain in response to
changing thyroid levels brought on by
thyroid effect in the parents. A database
uncertainty factor of 10X is placed on
fluindapyr to address this concern.
ii. In the acute neurotoxicity study
(ACN), decreases in total and
ambulatory motor activities and in
rearing were seen and could be
considered as potential evidence for
neurotoxicity. However, concern with
fluindapyr is low because (1) no other
effects were observed in database
including in the subchronic
neurotoxicity study (SCN); (2) no
neurohistopathology was found in the
ACN, SCN or any toxicity study in the
fluindapyr database; and (3) the toxicity
endpoints and PoD selected for risk
assessment are protective of the effects
seen in the ACN.
iii. There is no evidence that
fluindapyr results in increased
quantitative or qualitative susceptibility
in the developmental toxicity studies in
rabbits or rats or the reproductive
toxicity study in rats. In the 2generation reproduction study in rats,
reproductive effects were observed, and
offspring toxicity (decreased pup
weights in F1 and F2 generation;
thymus and spleen weights were
decreased) was observed in the presence
(same dosage) of parental toxicity. Based
on the effects in the 2-generation
reproduction study, there is some
uncertainty about the potential thyroidrelated effects on the developing fetus or
child. While EPA is retaining the 10X
FQPA SF for short-term aggregate risk
assessment, there is no concern for this
uncertainty for the acute dietary
exposure assessment because
perturbation of thyroid after a single
dose is not anticipated to impact the
developing fetus or offspring. Nor is
there a concern for this uncertainty in
the chronic dietary assessment because
the chronic dietary endpoint, based on
E:\FR\FM\09MRR1.SGM
09MRR1
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES
effects in dogs, is protective of potential
thyroid-related effects observed in
developing rats or offspring.
iv. There are no residual uncertainties
identified in the exposure databases.
The dietary risk assessments are based
on high-end assumptions such as 100
PCT assumptions, HAFT and field trial
mean residue values, empirical and
default processing factors, anticipated
livestock residues based on calculated
livestock dietary burden and tissue
transfer rates from the livestock feeding
studies and modeled, high-end
estimates of residues in drinking water.
All of the exposure estimates are based
on high-end assumptions and are not
likely to underestimate risk. EPA made
conservative (protective) assumptions in
the ground and surface water modeling
used to assess exposure to fluindapyr in
drinking water. EPA used similarly
conservative assumptions to assess
postapplication exposure of children.
These assessments will not
underestimate the exposure and risks
posed by fluindapyr.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic dietary pesticide exposures are
safe by comparing aggregate exposure
estimates to the acute PAD (aPAD) and
chronic PAD (cPAD). For linear cancer
risks, EPA calculates the lifetime
probability of acquiring cancer given the
estimated aggregate exposure. Short-,
intermediate-, and chronic-term risks
are evaluated by comparing the
estimated aggregate food, water, and
residential exposure to the appropriate
PODs to ensure that an adequate MOE
exists.
1. Acute risk. Using the exposure
assumptions discussed in this unit for
acute exposure, the acute dietary
exposure from food and water to
fluindapyr will occupy 8.9% of the
aPAD for all infants (<1 year old), the
population group receiving the greatest
exposure.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to fluindapyr
from food and water will utilize 33% of
the cPAD for infants <1 year old, the
population group receiving the greatest
exposure. Based on the explanation in
Unit III.C.3., regarding residential use
patterns, chronic residential exposure to
residues of fluindapyr is not expected.
3. Short-term and intermediate-term
risk. Short-term and intermediate-term
aggregate exposure takes into account
short-term residential exposure plus
chronic exposure to food and water
(considered to be a background
VerDate Sep<11>2014
16:19 Mar 08, 2021
Jkt 253001
exposure level). Short-term and
intermediate-term endpoints and
residential exposure estimates are
identical, and so short-term aggregate
exposure is considered protective of
intermediate-term aggregate exposures.
The three population subgroups
assessed for residential post-application
exposures are: Adults, youth 11 to <16
years old, and children 6 to <11 years
old. Of the three population subgroups,
the children 6 to <11 years old represent
the highest dermal exposure from postapplication exposures and the highest
background dietary exposure. Therefore,
this population subgroup is considered
protective of the other two population
subgroups.
For adults, intermediate-term
exposure is not expected for the
residential exposure pathway.
Therefore, the intermediate-term
aggregate risk would be equivalent to
the chronic dietary exposure estimate.
For children, all intermediate-term
aggregate risks are equivalent to shortterm aggregate risks.
Using the exposure assumptions
described in this unit for short-term and
intermediate-term exposures, EPA has
concluded the combined short- and
intermediate term food, water, and
residential exposures result in aggregate
MOEs of 720 for youth (6 to <11 yrs.
old) with dermal exposure from postapplication exposure to residue from
treated golf course. Because EPA’s level
of concern for fluindapyr is a MOE of
100 or below, these MOEs are not of
concern.
4. Aggregate cancer risk for U.S.
population. Based on the lack of
evidence of carcinogenicity in two
adequate rodent carcinogenicity studies,
fluindapyr is not expected to pose a
cancer risk to humans.
5. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population, or to infants and children
from aggregate exposure to fluindapyr
residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
The petitioner has proposed a liquid
chromatography with tandem mass
spectrometer (LC/MS/MS) for
determination of fluindapyr and
metabolites 3–OH–F9990, F9990–DMglucoside, 1–OH-Me-F9990, 1–OH-MeDM–F9990, and 1–COOH–F9990 in
plant commodities. For livestock
commodities, adequate enforcement
methodology using LC/MS/MS is
available for determination of residues
of fluindapyr and its metabolites.
PO 00000
Frm 00021
Fmt 4700
Sfmt 4700
13463
The method may be requested from:
Chief, Analytical Chemistry Branch,
Environmental Science Center, 701
Mapes Rd., Ft. Meade, MD 20755–5350;
telephone number: (410) 305–2905;
email address: residuemethods@
epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
possible, consistent with U.S. food
safety standards and agricultural
practices. EPA considers the
international maximum residue limits
(MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
The Codex Alimentarius is a joint
United Nations Food and Agriculture
Organization/World Health
Organization food standards program,
and it is recognized as an international
food safety standards-setting
organization in trade agreements to
which the United States is a party. EPA
may establish a tolerance that is
different from a Codex MRL; however,
FFDCA section 408(b)(4) requires that
EPA explain the reasons for departing
from the Codex level.
The Codex has not established an
MRL for fluindapyr.
C. Response to Comments
One comment was received in
response to the notice of filing that
argued against the use fluindapyr on
several commodities and the overall
toxicity of pesticides. In addition, the
commenter raised three additional
concerns: The lack of tests involving the
combination of fluindapyr and other
chemicals; fluindapyr a potential
cancer-causing agent; and fluindapyr is
a fluoride compound. Although the
Agency recognizes that some
individuals believe that pesticides
should be banned on agricultural crops,
the existing legal framework provided
by section 408 of the Federal Food,
Drug, and Cosmetic Act (FFDCA)
authorized EPA to establish tolerances
when it determines that the tolerance is
safe. Upon consideration of the validity,
completeness, and reliability of the
available data as well as other factors
the FFDCA requires EPA to consider,
EPA has determined that these
fluindapyr tolerances are safe. The
commenter has provided no information
supporting a contrary conclusion.
In its assessment of safety under the
FFDCA, EPA considers combinations of
pesticides by evaluating the cumulative
effects of pesticides that have a common
mechanism of toxicity. At this time,
EPA has not identified a common
E:\FR\FM\09MRR1.SGM
09MRR1
13464
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES
mechanism of toxicity between
fluindapyr and other pesticides and
thus there are no combinations of
pesticides to consider at this time.
EPA has evaluated available data
concerning carcinogenicity and
determined that fluindapyr is not likely
to be carcinogenic to humans. This
conclusion is based on a lack of
treatment-related tumors seen in male or
female rats or mice and no concern for
mutagenicity. The commenter has
provided no additional information
about potential carcinogenicity.
Fluindapyr contains a difluoromethyl
group and a fluorine-substituted phenyl
group. The difluoromethyl group
remains intact on the compounds
identified in crop (primary and
rotational), livestock, and
environmental fate studies, including
the compounds identified as the
residues of concern for tolerance
enforcement and risk assessment
purposes for crop and livestock
commodities. While the metabolism
studies show the phenyl group does
degrade, it is extremely unlikely for the
fluorine to form a free fluorine because
the stability of the bond between the
fluorine and carbon atom. Therefore,
applications of fluindapyr are not
expected to result in dietary exposure to
fluoride.
D. Revisions to Petitioned-For
Tolerances
Based on EPA’s review of the data
supporting the petition, EPA is
establishing tolerances that vary from
what the petitioner requested under its
authority in FFDCA section
408(d)(4)(A)(i). Some commodity terms
are altered to be consistent with Agency
nomenclature. EPA is not establishing
tolerances for corn oil since EPA
determined that residues on this
commodity will be adequately covered
under corn, field, grain due to the lack
of concentration during processing. EPA
is also not establishing tolerances for
fruit, small vine-climbing except fuzzy
kiwifruit, crop subgroup 13–07F and the
soybean commodities as initially
requested since they are not necessary at
this time, due to the withdrawal of the
proposed uses by the petitioner.
EPA is establishing tolerance levels
lower than what the petitioner
requested for grain, aspirated fractions;
grain, cereal, group 15, except rice and
corn from 0.9 ppm; and cattle, fat based
on the submitted field trial data for
those commodities using the OEDC
MRL (Maximum Residue Limit)
calculator.
Because of potential increase of
fluindapyr (including metabolites and
degradates) in livestock diet, largely due
VerDate Sep<11>2014
16:19 Mar 08, 2021
Jkt 253001
to cereal grain crop group 15 and 16 use,
and based on updated maximum
reasonably balanced diet (MRBD)
calculations for livestock, the Agency
has determined that finite residues will
be incurred in poultry (egg, fat, meat,
and meat byproducts), ruminants (fat,
milk, meat, and meat byproducts), hog
(fat, meat, and meat byproducts), and
horse (fat, meat, and meat byproducts);
therefore, under 40 CFR 180.6, EPA is
establishing tolerances for those
commodities.
V. Conclusion
Therefore, tolerances are established
for residues of fluindapyr, 3(difluoromethyl)-N-(7-fluoro-2,3dihydro-1,1,3-trimethyl-1H-inden-4-yl)1-methyl-1H-pyrazole-4-carboxamide, in
or on almond, hulls at 15 ppm ; corn,
field, grain at 0.01 ppm; corn, sweet,
kernel plus cob with husks removed at
0.01 ppm; corn, sweet, stover at 20 ppm;
grain, aspirated fractions at 20 ppm;
grain, cereal, forage, fodder, and straw,
group 16 forage, except rice at 15 ppm;
grain, cereal, forage, fodder, and straw,
group 16, hay, except rice at 8 ppm;
grain, cereal, forage, fodder, and straw,
group 16, stover, except rice at 4 ppm;
grain, cereal, forage, fodder, and straw,
group 16, straw, except rice at 20 ppm;
grain, cereal, group 15, except rice and
corn at 0.8 ppm; nut, tree, group 14–12
at 0.04 ppm; egg at 0.01 ppm; milk at
0.01 ppm; cattle, fat at 0.03 ppm; cattle,
meat at 0.01; goat, fat at 0.03 ppm; goat,
meat at 0.01 ppm; hog, fat at 0.01 ppm;
hog, meat at 0.01 ppm; horse, fat at 0.03
ppm; horse, meat at 0.01 ppm; poultry,
fat at 0.01 ppm; poultry, meat at 0.01
ppm; sheep, fat at 0.03 ppm; and sheep,
meat at 0.01 ppm. In addition,
tolerances are established for residues of
fluindapyr, 3-(difluoromethyl)-N-(7fluoro-1,1,3-trimethyl-2,3-dihydro-1Hinden-4-yl)-1-methyl-1H-pyrazole-4carboxamide, and 3-(difluoromethyl)-N(7-fluoro-1-hydroxymethyl-1,3dimethyl-2,3-dihydro-lH-inden-4-yl)-1methyl-lH-pyrazole-4-carboxamide, in
or on cattle, meat byproducts at 0.3
ppm; goat, meat byproducts at 0.3 ppm;
horse, meat byproducts at 0.3 ppm; hog,
meat byproducts at 0.01 ppm; poultry,
meat byproducts at 0.01 ppm; and
sheep, meat byproducts at 0.3 ppm.
VI. Statutory and Executive Order
Reviews
This action establishes tolerances
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
PO 00000
Frm 00022
Fmt 4700
Sfmt 4700
October 4, 1993). Because this action
has been exempted from review under
Executive Order 12866, this action is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001) or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997). This action does not
contain any information collections
subject to OMB approval under the
Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et seq.), nor does it require
any special considerations under
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers,
food processors, food handlers, and food
retailers, not States or Tribes, nor does
this action alter the relationships or
distribution of power and
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or Tribal Governments, on the
relationship between the National
Government and the States or Tribal
Governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
Tribes. Thus, the Agency has
determined that Executive Order 13132,
entitled ‘‘Federalism’’ (64 FR 43255,
August 10, 1999) and Executive Order
13175, entitled ‘‘Consultation and
Coordination with Indian Tribal
Governments’’ (65 FR 67249, November
9, 2000) do not apply to this action. In
addition, this action does not impose
any enforceable duty or contain any
unfunded mandate as described under
Title II of the Unfunded Mandates
Reform Act (UMRA) (2 U.S.C. 1501 et
seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act
(NTTAA) (15 U.S.C. 272 note).
E:\FR\FM\09MRR1.SGM
09MRR1
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Rules and Regulations
VII. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
TABLE 1 TO PARAGRAPH (a)(1)—
Continued
Grain, cereal group 15, except rice and
corn ......................................................
Hog, fat ....................................................
Hog, meat ................................................
Horse, fat .................................................
Horse, meat .............................................
Milk ..........................................................
Nut, tree, group 14–12 ............................
Poultry, fat ...............................................
Poultry, meat ...........................................
Sheep, fat ................................................
Sheep, meat ............................................
Therefore, 40 CFR chapter I is
amended as follows:
PART 180—TOLERANCES AND
EXEMPTIONS FOR PESTICIDE
CHEMICAL RESIDUES IN FOOD
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. Add § 180.716 to subpart C to read
as follows:
■
TABLE 2 TO PARAGRAPH (a)(2)
§ 180.716 Fluindapyr; tolerances for
residues.
(a) General. (1) Tolerances are
established for residues of the fungicide
fluindapyr, including its metabolites
and degradates, in or on the
commodities in Table 1 of this section.
Compliance with the tolerance levels
specified in Table 1 is to be determined
by measuring only fluindapyr, 3(difluoromethyl)-N-(7-fluoro-1,1,3trimethyl-2,3-dihydro-1H-inden-4-yl)-1methyl-1H-pyrazole-4-carboxamide, in
or on the commodity.
TABLE 1 TO PARAGRAPH (a)(1)
khammond on DSKJM1Z7X2PROD with RULES
VerDate Sep<11>2014
16:19 Mar 08, 2021
Jkt 253001
Parts per
million
Commodity
Cattle, meat byproducts ..........................
Goat, meat byproducts ............................
Horse, meat byproducts ..........................
Hog, meat byproducts .............................
Poultry, meat byproducts ........................
Sheep, meat byproducts .........................
0.3
0.3
0.3
0.01
0.01
0.3
(b)–(d) [Reserved]
[FR Doc. 2021–04786 Filed 3–8–21; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF THE INTERIOR
Parts per
million
Almond, hulls ...........................................
Cattle, fat .................................................
Cattle, meat .............................................
Corn, field, grain ......................................
Corn, sweet, kernel plus cob with husks
removed ...............................................
Corn, sweet, stover .................................
Egg ..........................................................
Goat, fat ..................................................
Goat, meat ..............................................
Grain, aspirated fractions ........................
Grain, cereal, forage, fodder, and straw,
group 16, forage, except rice ..............
Grain, cereal, forage, fodder, and straw,
group 16, hay, except rice ...................
Grain, cereal, forage, fodder, and straw,
group 16, stover, except rice ...............
Grain, cereal forage, fodder, and straw,
group 16, straw, except rice ................
0.8
0.01
0.01
0.03
0.01
0.01
0.04
0.01
0.01
0.03
0.01
(2) Tolerances are established for
residues of the fungicide fluindapyr,
including its metabolites and
degradates, in or on the commodities in
Table 2 of this section. Compliance with
the tolerance levels specified in Table 2
is to be determined by measuring the
sum of fluindapyr, 3-(difluoromethyl)N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro1H-inden-4-yl)-1-methyl-1H-pyrazole-4carboxamide, and 3-(difluoromethyl)-N(7-fluoro-1-hydroxymethyl-1,3dimethyl-2,3-dihydro-lH-inden-4-yl)-1methyl-lH-pyrazole-4-carboxamide,
calculated as the stoichiometric
equivalent of fluindapyr, in or on the
commodity.
Edward Messina,
Acting Director, Office of Pesticide Programs.
Commodity
Parts per
million
Commodity
Fish and Wildlife Service
15
0.03
0.01
0.01
50 CFR Part 17
0.01
20
0.01
0.03
0.01
20
RIN 1018–BD26
15
8
4
20
[Docket No. FWS–R3–ES–2018–0056;
FF09E21000 FXES11110900000 212]
Endangered and Threatened Wildlife
and Plants; Endangered Species
Status for the Missouri Distinct
Population Segment of Eastern
Hellbender
Fish and Wildlife Service,
Interior.
ACTION: Final rule.
AGENCY:
PO 00000
Frm 00023
Fmt 4700
Sfmt 4700
13465
We, the U.S. Fish and
Wildlife Service (Service), determine
endangered species status under the
Endangered Species Act of 1973 (Act),
as amended, for the Missouri distinct
population segment (DPS) of eastern
hellbender (Cryptobranchus
alleganiensis alleganiensis), a
salamander species. This rule adds this
DPS of this species to the Federal List
of Endangered and Threatened Wildlife.
DATES: This rule is effective April 8,
2021.
ADDRESSES: This final rule is available
on the internet at https://
www.regulations.gov in Docket No.
FWS–R3–ES–2018–0056 and https://
www.fws.gov/midwest/endangered/
amphibians/eastern_hellbender/.
Comments and materials we received, as
well as supporting documentation we
used in preparing this rule, are available
for public inspection at https://
www.regulations.gov. Comments,
materials, and documentation that we
considered in this rulemaking will be
available by appointment, during
normal business hours, at: U.S. Fish and
Wildlife Service, Columbia, Missouri
Ecological Services Field Office, 101
Park DeVille Drive, Suite A, Columbia,
MO 65203–0057; telephone 573–234–
2132.
FOR FURTHER INFORMATION CONTACT:
Karen Herrington, Field Supervisor,
Missouri Ecological Services Field
Office, 101 Park DeVille Drive, Suite A,
Columbia, MO 65203; telephone 573–
234–2132. Persons who use a
telecommunications device for the deaf
(TDD) may call the Federal Relay
Service at 800–877–8339.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Previous Federal Actions
On April 4, 2019, we published a
proposed rule (84 FR 13223) to add the
Missouri DPS of the eastern hellbender
as an endangered species to the List of
Endangered and Threatened Wildlife in
part 17 of title 50 of the Code of Federal
Regulations (at 50 CFR 17.11(h)). We
concurrently published a not warranted
finding on the listing of the eastern
hellbender subspecies as a whole. See
the proposed listing rule for the
Missouri DPS of the eastern hellbender
for more information regarding the
previous Federal actions on the
hellbender species and related
subspecies.
Background
The Missouri DPS of the eastern
hellbender lies completely within the
boundaries of the State of Missouri with
eastern hellbenders known to occur in
Big River, Big Piney River, Courtois
E:\FR\FM\09MRR1.SGM
09MRR1
Agencies
[Federal Register Volume 86, Number 44 (Tuesday, March 9, 2021)]
[Rules and Regulations]
[Pages 13459-13465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04786]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2018-0551; FRL-10019-19]
Fluindapyr; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
fluindapyr in or on multiple commodities which are identified and
discussed later in this document. FMC Corporation requested these
tolerances under the Federal Food, Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective March 9, 2021. Objections and
requests for hearings must be received on or before May 10, 2021, and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2018-0551, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW, Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPP
Docket is (703) 305-5805.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Marietta Echeverria, Registration
Division (7505P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; main
[[Page 13460]]
telephone number: (703) 305-7090; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Government
Publishing Office's e-CFR site at https://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2018-0551 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing and must be received by the Hearing Clerk on or before
May 10, 2021. Addresses for mail and hand delivery of objections and
hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2018-0551, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
II. Summary of Petitioned-For Tolerance
In the Federal Register of May 9, 2019 (84 FR 20320) (FRL-9992-36),
EPA issued a document pursuant to FFDCA section 408(d)(3), 21 U.S.C.
346a(d)(3), announcing the filing of a pesticide petition (PP 8F8685)
by FMC Corporation, 2929 Walnut Street, Philadelphia, PA 19104. The
petition requested that 40 CFR part 180 be amended by establishing
tolerances for residues of the fungicide, fluindapyr, 3-
(difluoromethyl)-N-(7-fluoro-2,3-dihydro-1,1,3-trimethyl-1H-inden-4-
yl)-1-methyl-1H-pyrazole-4-carboxamide, in or on almond, hulls at 15
parts per million (ppm); aspirated grain fractions at 60 ppm; cattle,
fat at 0.15 ppm; cattle, meat byproducts at 0.6 ppm; field corn, grain
at 0.01 ppm; field corn, oil at 0.03 ppm; fruit, small vine-climbing
except fuzzy kiwifruit, crop subgroup 13-07F at 3 ppm; grain, cereal,
crop group 15, except rice and corn at 0.9 ppm; grain, cereal, forage,
crop group 16, except rice, forage at 15 ppm; grain, cereal, hay, crop
group 16 except rice, hay at 8 ppm; grain, cereal, stover, crop group
16 except rice, stover, and sweet corn stover at 4 ppm; grain, cereal,
straw, crop group 16, except rice, straw at 20 ppm; poultry, meat
byproducts at 0.03 ppm; soybean, forage at 15 ppm; soybean, hay at 30
ppm; soybean, hulls at 0.6 ppm; soybean, seed at 0.2 ppm; sweet corn,
K+CWHR at 0.01 ppm; sweet corn, stover at 20 ppm; swine, meat
byproducts at 0.02 ppm; and tree nuts, crop group 14-12 at 0.04 ppm.
That document referenced a summary of the petition prepared by FMC
Corporation, the registrant, which is available in the docket, https://www.regulations.gov. One comment was received on the notice of filing.
EPA's response to this comment is discussed in Unit IV.C.
Based upon review of the data supporting the petition and in
accordance with its authority under FFDCA section 408(d)(4)(A)(i) to
establish tolerances that vary from what was requested, EPA is
establishing several tolerances at different levels than were
requested, including additional livestock commodities as necessary. In
addition, tolerances for fruit, small vine-climbing except fuzzy
kiwifruit crop group 13-07F and soybeans were removed. The reasons for
these changes are explained in Unit IV.D.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. . .
.''
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for fluindapyr including exposure
resulting from the tolerances established by this action. EPA's
assessment of exposures and risks associated with fluindapyr follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable
[[Page 13461]]
subgroups of consumers, including infants and children.
The target organs of fluindapyr are the liver and thyroid. Liver
effects include hepatocellular hypertrophy, increased liver weights,
and bile duct hyperplasia with correlated increases in alkaline
phosphatase (ALP), alanine aminotransferase (ALT), and gamma glutamyl
transferase (GGT) at the highest dose tested. Liver effects progress
with time in treated dogs, while similar effects are not seen in rats
and mice at high dose levels. Liver effects are seen in the mouse
carcinogenicity study at a higher dose level than the liver effects
observed in dogs; the effects consisted of increased incidence of
hepatocellular alterations (basophilic, eosinophilic, vacuolated),
necrosis, and pigmented macrophages. Thyroid effects include increased
instances of follicular hypertrophy/hyperplasia.
In the acute neurotoxicity study, potential evidence of
neurotoxicity in the form of decreases in total and ambulatory motor
activities and in rearing were seen in the rat. However, no additional
functional observation (FOB) parameters were affected, and no
neuropathological findings of both central and peripheral nerves were
observed.
There is no evidence of increased quantitative or qualitative
susceptibility in the developmental toxicity studies in rabbits or
rats; or the reproductive toxicity study in rats. With in-utero
exposure in the developmental toxicity studies, fluindapyr did not
produce any adverse effects in either rat or rabbit parental animals or
fetuses at or approaching the limit dose. In the reproduction study, in
parental animals (P and F1 males and females), fluindapyr induced an
increase in thyroid follicular hypertrophy/hyperplasia. It also induced
adverse effects on a host of reproductive parameters. It also produced
adverse offspring effects as indicated by decreases in F1 and F2 pup
body weights in both sexes; thymus and spleen weights were also
decreased. The parental, reproductive, and offspring effects all
occurred at the same dose levels. The increased incidence of thyroid
follicular hypertrophy/hyperplasia raised concerns for the potential of
thyroid effects on the developing animals. EPA applied a 10X safety
factor to the appropriate exposure scenarios to account for the
uncertainties associated with the life stage susceptibility.
In the chronic toxicity/carcinogenicity studies in rats and mice,
there was no evidence of carcinogenicity. The mutagenicity battery was
negative. Fluindapyr is classified as ``Not Likely to be Carcinogenic
to Humans''.
Specific information on the studies received and the nature of the
adverse effects caused by fluindapyr as well as the no-observed-
adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-
level (LOAEL) from the toxicity studies can be found at https://www.regulations.gov in document ``Fluindapyr: Human Health Risk
Assessment for Section 3 Registration and Tolerance Requests for a New
Active Ingredient Proposed for Use on Cereal Grains Crop Group 15
except Rice; Forage, Fodder and Straw of Cereal Grains Crop Group 16;
and Soybean'' (hereinafter ``Fluindapyr Human Health Risk Assessment'')
on pages 14-20 in docket ID number EPA-HQ-OPP-2018-0551.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level--generally referred to as a
population-adjusted dose (PAD) or a reference dose (RfD)--and a safe
margin of exposure (MOE). For non-threshold risks, the Agency assumes
that any amount of exposure will lead to some degree of risk. Thus, the
Agency estimates risk in terms of the probability of an occurrence of
the adverse effect expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/assessing-human-health-risk-pesticide.
A summary of the toxicological endpoints for fluindapyr used for
human risk assessment can be found in the Fluindapyr Human Health Risk
Assessment.
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to fluindapyr, EPA considered exposure under the petitioned-
for tolerances. EPA assessed dietary exposures from fluindapyr in food
as follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure. Such effects were identified
for fluindapyr. In estimating acute dietary exposure, EPA used 2003-
2008 food consumption information from the United States Department of
Agriculture (USDA) Nationwide Health and Nutrition Examination Survey,
What We Eat in America (NHANES/WWEIA). As to residue levels in food,
the acute analysis assumed 100% crop treated (PCT) for all commodities,
highest average field trial (HAFT) residue values, empirical and
default processing factors, and anticipated livestock residues based on
calculated livestock dietary burden and tissue transfer rates from the
livestock feeding studies.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used 2003-2008 food consumption data from the USDA's
NHANES/WWEIA. As to residue levels in food, chronic analysis assumed
100 PCT for all commodities, field trial mean residue values, empirical
and default processing factors, and anticipated livestock residues
based on calculated livestock dietary burden and tissue transfer rates
from the livestock feeding studies and metabolite ratios from the
metabolism studies.
iii. Cancer. Based on the data summarized in Unit III.A., EPA has
concluded that fluindapyr does not pose a cancer risk to humans.
Therefore, a dietary exposure assessment for the purpose of assessing
cancer risk is unnecessary.
iv. Anticipated residue. Section 408(b)(2)(E) of FFDCA authorizes
EPA to use available data and information on the anticipated residue
levels of pesticide residues in food and the actual levels of pesticide
residues that have been measured in food. If EPA relies on such
information, EPA must require pursuant to FFDCA section 408(f)(1) that
data be provided 5 years after the tolerance is established, modified,
or left in effect, demonstrating that the levels in food are not above
the levels anticipated. For the present action, EPA will issue such
data call-ins as are required by FFDCA section 408(b)(2)(E)
[[Page 13462]]
and authorized under FFDCA section 408(f)(1). Data will be required to
be submitted no later than 5 years from the date of issuance of these
tolerances.
EPA did not use information on the percent of food actually treated
in the dietary assessment for fluindapyr; 100 PCT was assumed for all
food commodities.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for fluindapyr in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of fluindapyr. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/about-water-exposure-models-used-pesticide.
Using the Pesticide Water Calculator (PWC, version 1.52), the
estimated drinking water concentrations (EDWCs) of fluindapyr were
determined to be higher in groundwater than in surface water for both
acute and chronic exposure durations. The following groundwater EDWCs
were used directly in the dietary exposure model to account for the
contribution of fluindapyr and relevant transformation products (3-OH-
F9990 and 1-COOH-F9990) residues in drinking water as follows: 254.1
ppb was used in the acute assessment and 217.8 ppb was used in the
chronic assessment.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets).
Fluindapyr is currently registered for the following use that could
result in residential exposures: Golf course turf. The currently
registered use on golf courses will result in short-term (1 to 30 days)
residential post-application dermal exposures to adult, youth 11 to
less than 16 years old, and children 6 to less than 11 years old.
Further information regarding EPA standard assumptions and generic
inputs for residential exposures may be found at https://www.epa.gov/pesticides/trac/science/trac6a05.pdf.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
Unlike other pesticides for which EPA has followed a cumulative
risk approach based on a common mechanism of toxicity, EPA has not made
a common mechanism of toxicity finding as to fluindapyr and any other
substances and fluindapyr does not appear to produce a toxic metabolite
produced by other substances. For the purposes of this action,
therefore, EPA has not assumed that fluindapyr has a common mechanism
of toxicity with other substances.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA Safety
Factor (SF). In applying this provision, EPA either retains the default
value of 10X, or uses a different additional safety factor when
reliable data available to EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity. In the developmental
toxicity studies (rat and rabbit), fluindapyr did not produce any
adverse effects in parental animals or fetuses at or approaching the
limit dose (1,000 mg/kg/day). In the reproduction study, in parental
animals (P and F1 males and females), fluindapyr induced an increase in
thyroid follicular hypertrophy/hyperplasia. It also induced adverse
effects on a host of reproductive parameters. There is no evidence of
increased quantitative or qualitative susceptibility in the
developmental toxicity studies in rabbits or rats or the reproductive
toxicity study in rats. In the 2-generation reproduction study in rats,
reproductive effects were observed, and offspring toxicity (decreased
pup weights in F1 and F2 generation; thymus and spleen weights were
decreased) was observed in the presence (same dosage) of parental
toxicity (increase in thyroid follicular hypertrophy/hyperplasia and
reproductive effects).
3. Conclusion. Due to the uncertainties concerning the potential
life stage susceptibility related to adverse thyroid effects seen in
parental animals of the reproductive study, EPA is retaining the FQPA
10X SF for exposure scenarios that rely on the reproductive study in
which such effects were seen. For purposes of this safety assessment,
those scenarios are the post-application short-term dermal exposures
and the short-term aggregate risk assessment. For the acute and chronic
dietary assessments, EPA has determined that reliable data show the
safety of infants and children would be adequately protected if the
FQPA SF were reduced to 1X. That decision is based on the following
findings:
i. The toxicity database for fluindapyr is complete. Fluindapyr
caused an increased in the thyroid follicular hypertrophy/hyperplasia
in the 2-generation reproduction study. The results of these findings
raised concerns about the potential impact to the developing brain in
response to changing thyroid levels brought on by thyroid effect in the
parents. A database uncertainty factor of 10X is placed on fluindapyr
to address this concern.
ii. In the acute neurotoxicity study (ACN), decreases in total and
ambulatory motor activities and in rearing were seen and could be
considered as potential evidence for neurotoxicity. However, concern
with fluindapyr is low because (1) no other effects were observed in
database including in the subchronic neurotoxicity study (SCN); (2) no
neurohistopathology was found in the ACN, SCN or any toxicity study in
the fluindapyr database; and (3) the toxicity endpoints and PoD
selected for risk assessment are protective of the effects seen in the
ACN.
iii. There is no evidence that fluindapyr results in increased
quantitative or qualitative susceptibility in the developmental
toxicity studies in rabbits or rats or the reproductive toxicity study
in rats. In the 2-generation reproduction study in rats, reproductive
effects were observed, and offspring toxicity (decreased pup weights in
F1 and F2 generation; thymus and spleen weights were decreased) was
observed in the presence (same dosage) of parental toxicity. Based on
the effects in the 2-generation reproduction study, there is some
uncertainty about the potential thyroid-related effects on the
developing fetus or child. While EPA is retaining the 10X FQPA SF for
short-term aggregate risk assessment, there is no concern for this
uncertainty for the acute dietary exposure assessment because
perturbation of thyroid after a single dose is not anticipated to
impact the developing fetus or offspring. Nor is there a concern for
this uncertainty in the chronic dietary assessment because the chronic
dietary endpoint, based on
[[Page 13463]]
effects in dogs, is protective of potential thyroid-related effects
observed in developing rats or offspring.
iv. There are no residual uncertainties identified in the exposure
databases. The dietary risk assessments are based on high-end
assumptions such as 100 PCT assumptions, HAFT and field trial mean
residue values, empirical and default processing factors, anticipated
livestock residues based on calculated livestock dietary burden and
tissue transfer rates from the livestock feeding studies and modeled,
high-end estimates of residues in drinking water. All of the exposure
estimates are based on high-end assumptions and are not likely to
underestimate risk. EPA made conservative (protective) assumptions in
the ground and surface water modeling used to assess exposure to
fluindapyr in drinking water. EPA used similarly conservative
assumptions to assess postapplication exposure of children. These
assessments will not underestimate the exposure and risks posed by
fluindapyr.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing aggregate exposure estimates to the
acute PAD (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA
calculates the lifetime probability of acquiring cancer given the
estimated aggregate exposure. Short-, intermediate-, and chronic-term
risks are evaluated by comparing the estimated aggregate food, water,
and residential exposure to the appropriate PODs to ensure that an
adequate MOE exists.
1. Acute risk. Using the exposure assumptions discussed in this
unit for acute exposure, the acute dietary exposure from food and water
to fluindapyr will occupy 8.9% of the aPAD for all infants (<1 year
old), the population group receiving the greatest exposure.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
fluindapyr from food and water will utilize 33% of the cPAD for infants
<1 year old, the population group receiving the greatest exposure.
Based on the explanation in Unit III.C.3., regarding residential use
patterns, chronic residential exposure to residues of fluindapyr is not
expected.
3. Short-term and intermediate-term risk. Short-term and
intermediate-term aggregate exposure takes into account short-term
residential exposure plus chronic exposure to food and water
(considered to be a background exposure level). Short-term and
intermediate-term endpoints and residential exposure estimates are
identical, and so short-term aggregate exposure is considered
protective of intermediate-term aggregate exposures. The three
population subgroups assessed for residential post-application
exposures are: Adults, youth 11 to <16 years old, and children 6 to <11
years old. Of the three population subgroups, the children 6 to <11
years old represent the highest dermal exposure from post-application
exposures and the highest background dietary exposure. Therefore, this
population subgroup is considered protective of the other two
population subgroups.
For adults, intermediate-term exposure is not expected for the
residential exposure pathway. Therefore, the intermediate-term
aggregate risk would be equivalent to the chronic dietary exposure
estimate. For children, all intermediate-term aggregate risks are
equivalent to short-term aggregate risks.
Using the exposure assumptions described in this unit for short-
term and intermediate-term exposures, EPA has concluded the combined
short- and intermediate term food, water, and residential exposures
result in aggregate MOEs of 720 for youth (6 to <11 yrs. old) with
dermal exposure from post-application exposure to residue from treated
golf course. Because EPA's level of concern for fluindapyr is a MOE of
100 or below, these MOEs are not of concern.
4. Aggregate cancer risk for U.S. population. Based on the lack of
evidence of carcinogenicity in two adequate rodent carcinogenicity
studies, fluindapyr is not expected to pose a cancer risk to humans.
5. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to fluindapyr residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
The petitioner has proposed a liquid chromatography with tandem
mass spectrometer (LC/MS/MS) for determination of fluindapyr and
metabolites 3-OH-F9990, F9990-DM-glucoside, 1-OH-Me-F9990, 1-OH-Me-DM-
F9990, and 1-COOH-F9990 in plant commodities. For livestock
commodities, adequate enforcement methodology using LC/MS/MS is
available for determination of residues of fluindapyr and its
metabolites.
The method may be requested from: Chief, Analytical Chemistry
Branch, Environmental Science Center, 701 Mapes Rd., Ft. Meade, MD
20755-5350; telephone number: (410) 305-2905; email address:
[email protected].
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level.
The Codex has not established an MRL for fluindapyr.
C. Response to Comments
One comment was received in response to the notice of filing that
argued against the use fluindapyr on several commodities and the
overall toxicity of pesticides. In addition, the commenter raised three
additional concerns: The lack of tests involving the combination of
fluindapyr and other chemicals; fluindapyr a potential cancer-causing
agent; and fluindapyr is a fluoride compound. Although the Agency
recognizes that some individuals believe that pesticides should be
banned on agricultural crops, the existing legal framework provided by
section 408 of the Federal Food, Drug, and Cosmetic Act (FFDCA)
authorized EPA to establish tolerances when it determines that the
tolerance is safe. Upon consideration of the validity, completeness,
and reliability of the available data as well as other factors the
FFDCA requires EPA to consider, EPA has determined that these
fluindapyr tolerances are safe. The commenter has provided no
information supporting a contrary conclusion.
In its assessment of safety under the FFDCA, EPA considers
combinations of pesticides by evaluating the cumulative effects of
pesticides that have a common mechanism of toxicity. At this time, EPA
has not identified a common
[[Page 13464]]
mechanism of toxicity between fluindapyr and other pesticides and thus
there are no combinations of pesticides to consider at this time.
EPA has evaluated available data concerning carcinogenicity and
determined that fluindapyr is not likely to be carcinogenic to humans.
This conclusion is based on a lack of treatment-related tumors seen in
male or female rats or mice and no concern for mutagenicity. The
commenter has provided no additional information about potential
carcinogenicity.
Fluindapyr contains a difluoromethyl group and a fluorine-
substituted phenyl group. The difluoromethyl group remains intact on
the compounds identified in crop (primary and rotational), livestock,
and environmental fate studies, including the compounds identified as
the residues of concern for tolerance enforcement and risk assessment
purposes for crop and livestock commodities. While the metabolism
studies show the phenyl group does degrade, it is extremely unlikely
for the fluorine to form a free fluorine because the stability of the
bond between the fluorine and carbon atom. Therefore, applications of
fluindapyr are not expected to result in dietary exposure to fluoride.
D. Revisions to Petitioned-For Tolerances
Based on EPA's review of the data supporting the petition, EPA is
establishing tolerances that vary from what the petitioner requested
under its authority in FFDCA section 408(d)(4)(A)(i). Some commodity
terms are altered to be consistent with Agency nomenclature. EPA is not
establishing tolerances for corn oil since EPA determined that residues
on this commodity will be adequately covered under corn, field, grain
due to the lack of concentration during processing. EPA is also not
establishing tolerances for fruit, small vine-climbing except fuzzy
kiwifruit, crop subgroup 13-07F and the soybean commodities as
initially requested since they are not necessary at this time, due to
the withdrawal of the proposed uses by the petitioner.
EPA is establishing tolerance levels lower than what the petitioner
requested for grain, aspirated fractions; grain, cereal, group 15,
except rice and corn from 0.9 ppm; and cattle, fat based on the
submitted field trial data for those commodities using the OEDC MRL
(Maximum Residue Limit) calculator.
Because of potential increase of fluindapyr (including metabolites
and degradates) in livestock diet, largely due to cereal grain crop
group 15 and 16 use, and based on updated maximum reasonably balanced
diet (MRBD) calculations for livestock, the Agency has determined that
finite residues will be incurred in poultry (egg, fat, meat, and meat
byproducts), ruminants (fat, milk, meat, and meat byproducts), hog
(fat, meat, and meat byproducts), and horse (fat, meat, and meat
byproducts); therefore, under 40 CFR 180.6, EPA is establishing
tolerances for those commodities.
V. Conclusion
Therefore, tolerances are established for residues of fluindapyr,
3-(difluoromethyl)-N-(7-fluoro-2,3-dihydro-1,1,3-trimethyl-1H-inden-4-
yl)-1-methyl-1H-pyrazole-4-carboxamide, in or on almond, hulls at 15
ppm ; corn, field, grain at 0.01 ppm; corn, sweet, kernel plus cob with
husks removed at 0.01 ppm; corn, sweet, stover at 20 ppm; grain,
aspirated fractions at 20 ppm; grain, cereal, forage, fodder, and
straw, group 16 forage, except rice at 15 ppm; grain, cereal, forage,
fodder, and straw, group 16, hay, except rice at 8 ppm; grain, cereal,
forage, fodder, and straw, group 16, stover, except rice at 4 ppm;
grain, cereal, forage, fodder, and straw, group 16, straw, except rice
at 20 ppm; grain, cereal, group 15, except rice and corn at 0.8 ppm;
nut, tree, group 14-12 at 0.04 ppm; egg at 0.01 ppm; milk at 0.01 ppm;
cattle, fat at 0.03 ppm; cattle, meat at 0.01; goat, fat at 0.03 ppm;
goat, meat at 0.01 ppm; hog, fat at 0.01 ppm; hog, meat at 0.01 ppm;
horse, fat at 0.03 ppm; horse, meat at 0.01 ppm; poultry, fat at 0.01
ppm; poultry, meat at 0.01 ppm; sheep, fat at 0.03 ppm; and sheep, meat
at 0.01 ppm. In addition, tolerances are established for residues of
fluindapyr, 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-
1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, and 3-
(difluoromethyl)-N-(7-fluoro-1-hydroxymethyl-1,3-dimethyl-2,3-dihydro-
lH-inden-4-yl)-1-methyl-lH-pyrazole-4-carboxamide, in or on cattle,
meat byproducts at 0.3 ppm; goat, meat byproducts at 0.3 ppm; horse,
meat byproducts at 0.3 ppm; hog, meat byproducts at 0.01 ppm; poultry,
meat byproducts at 0.01 ppm; and sheep, meat byproducts at 0.3 ppm.
VI. Statutory and Executive Order Reviews
This action establishes tolerances under FFDCA section 408(d) in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this action has been
exempted from review under Executive Order 12866, this action is not
subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997). This action does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor does it require any
special considerations under Executive Order 12898, entitled ``Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerance in this
final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or Tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
Tribal Governments, on the relationship between the National Government
and the States or Tribal Governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian Tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000) do not apply to this action. In addition, this
action does not impose any enforceable duty or contain any unfunded
mandate as described under Title II of the Unfunded Mandates Reform Act
(UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
[[Page 13465]]
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Edward Messina,
Acting Director, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180--TOLERANCES AND EXEMPTIONS FOR PESTICIDE CHEMICAL RESIDUES
IN FOOD
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Add Sec. 180.716 to subpart C to read as follows:
Sec. 180.716 Fluindapyr; tolerances for residues.
(a) General. (1) Tolerances are established for residues of the
fungicide fluindapyr, including its metabolites and degradates, in or
on the commodities in Table 1 of this section. Compliance with the
tolerance levels specified in Table 1 is to be determined by measuring
only fluindapyr, 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-
dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, in or on the
commodity.
Table 1 to Paragraph (a)(1)
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Almond, hulls................................................ 15
Cattle, fat.................................................. 0.03
Cattle, meat................................................. 0.01
Corn, field, grain........................................... 0.01
Corn, sweet, kernel plus cob with husks removed.............. 0.01
Corn, sweet, stover.......................................... 20
Egg.......................................................... 0.01
Goat, fat.................................................... 0.03
Goat, meat................................................... 0.01
Grain, aspirated fractions................................... 20
Grain, cereal, forage, fodder, and straw, group 16, forage, 15
except rice.................................................
Grain, cereal, forage, fodder, and straw, group 16, hay, 8
except rice.................................................
Grain, cereal, forage, fodder, and straw, group 16, stover, 4
except rice.................................................
Grain, cereal forage, fodder, and straw, group 16, straw, 20
except rice.................................................
Grain, cereal group 15, except rice and corn................. 0.8
Hog, fat..................................................... 0.01
Hog, meat.................................................... 0.01
Horse, fat................................................... 0.03
Horse, meat.................................................. 0.01
Milk......................................................... 0.01
Nut, tree, group 14-12....................................... 0.04
Poultry, fat................................................. 0.01
Poultry, meat................................................ 0.01
Sheep, fat................................................... 0.03
Sheep, meat.................................................. 0.01
------------------------------------------------------------------------
(2) Tolerances are established for residues of the fungicide
fluindapyr, including its metabolites and degradates, in or on the
commodities in Table 2 of this section. Compliance with the tolerance
levels specified in Table 2 is to be determined by measuring the sum of
fluindapyr, 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-
1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, and 3-
(difluoromethyl)-N-(7-fluoro-1-hydroxymethyl-1,3-dimethyl-2,3-dihydro-
lH-inden-4-yl)-1-methyl-lH-pyrazole-4-carboxamide, calculated as the
stoichiometric equivalent of fluindapyr, in or on the commodity.
Table 2 to Paragraph (a)(2)
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Cattle, meat byproducts...................................... 0.3
Goat, meat byproducts........................................ 0.3
Horse, meat byproducts....................................... 0.3
Hog, meat byproducts......................................... 0.01
Poultry, meat byproducts..................................... 0.01
Sheep, meat byproducts....................................... 0.3
------------------------------------------------------------------------
(b)-(d) [Reserved]
[FR Doc. 2021-04786 Filed 3-8-21; 8:45 am]
BILLING CODE 6560-50-P